       Document 0563
 DOCN  M9630563
 TI    Cost effectiveness and AIDS: science or marketing? Proceedings of a
       workshop. Washington, D.C., January 28, 1995.
 DT    9603
 SO    J Acquir Immune Defic Syndr Hum Retrovirol. 1995;10 Suppl 4:S1-32.
       Unique Identifier : AIDSLINE MED/96115223
 DE    Acquired Immunodeficiency Syndrome/DRUG THERAPY/*ECONOMICS  Antiviral
       Agents/*ECONOMICS/THERAPEUTIC USE  Cost-Benefit Analysis  Human  MEETING
       REPORT  OVERALL  JOURNAL ARTICLE

       SOURCE: National Library of Medicine.  NOTICE: This material may be
       protected by Copyright Law (Title 17, U.S.Code).

